Parallax Volatility Advisers
EDIT icon

Parallax Volatility Advisers’s Editas Medicine EDIT Stock Holding History

Parallax Volatility Advisers’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-15,000
Closed -$117K – 2247
2023
Q3 		$117K Hold
15,000
– – ﹤0.01% 1901
2023
Q2 		$123K Hold
15,000
– – ﹤0.01% 1972
2023
Q1 		$109K Hold
15,000
– – ﹤0.01% 2114
2022
Q4 		$133K Sell
15,000
-102,500
-87% -$1.13M ﹤0.01% 2223
2022
Q3 		$1.44M Hold
117,500
– – ﹤0.01% 1578
2022
Q2 		$1.39M Buy
117,500
+15,000
+15% +$201K ﹤0.01% 1511
2022
Q1 		$1.95M Buy
+102,500
New +$1.91M ﹤0.01% 1372

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Parallax Volatility Advisers's EDIT Position: Q4 2023 in Review

Parallax Volatility Advisers sold out of Editas Medicine (EDIT) in Q4 2023, closing a stake of 1,845 shares — an estimated $14.4K sold.

Parallax Volatility Advisers first reported a position in EDIT in Q4 2017 and held it in 9 quarters. The position peaked at $1.21M in Q1 2022. 225 funds tracked by Wall St. Rank hold EDIT as of Q4 2023.

  • Parallax Volatility Advisers reported no remaining Editas Medicine position as of Q4 2023 after selling out during the quarter.
  • Parallax Volatility Advisers sold 1,845 Editas Medicine shares in Q4 2023, an estimated $14.4K.
  • Parallax Volatility Advisers first reported a position in Editas Medicine in Q4 2017 and held it in 9 quarters.
  • Parallax Volatility Advisers's Editas Medicine position peaked at $1.21M in Q1 2022.
  • 225 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2023.

Based on Parallax Volatility Advisers's 13F filing for Q4 2023, filed 14 Feb 2024.